PHAXIAM Therapeutics SA (DELISTED) (PHXM:DL)
3.10
0.00 (0.00%)
USD |
NASDAQ |
Mar 11, 16:00
PHAXIAM Therapeutics Total Return Level
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| March 11, 2024 | 3.10 |
| March 08, 2024 | 3.10 |
| March 07, 2024 | 3.12 |
| March 06, 2024 | 3.01 |
| March 05, 2024 | 3.01 |
| March 04, 2024 | 2.50 |
| March 01, 2024 | 2.81 |
| February 29, 2024 | 2.74 |
| February 28, 2024 | 2.74 |
| February 27, 2024 | 2.989 |
| February 26, 2024 | 2.989 |
| February 23, 2024 | 2.905 |
| February 22, 2024 | 2.83 |
| February 21, 2024 | 2.83 |
| February 20, 2024 | 3.790 |
| February 16, 2024 | 3.70 |
| February 15, 2024 | 3.70 |
| February 14, 2024 | 3.75 |
| February 13, 2024 | 3.75 |
| February 12, 2024 | 3.75 |
| February 09, 2024 | 3.99 |
| February 08, 2024 | 3.99 |
| February 07, 2024 | 3.99 |
| February 06, 2024 | 4.02 |
| February 05, 2024 | 4.02 |
| Date | Value |
|---|---|
| February 02, 2024 | 4.025 |
| February 01, 2024 | 4.20 |
| January 31, 2024 | 4.21 |
| January 30, 2024 | 4.20 |
| January 29, 2024 | 4.40 |
| January 26, 2024 | 4.62 |
| January 25, 2024 | 4.43 |
| January 24, 2024 | 4.70 |
| January 23, 2024 | 4.75 |
| January 22, 2024 | 5.13 |
| January 19, 2024 | 4.70 |
| January 18, 2024 | 4.70 |
| January 17, 2024 | 5.19 |
| January 16, 2024 | 5.19 |
| January 12, 2024 | 4.80 |
| January 11, 2024 | 4.677 |
| January 10, 2024 | 4.677 |
| January 09, 2024 | 4.60 |
| January 08, 2024 | 5.31 |
| January 05, 2024 | 5.09 |
| January 04, 2024 | 5.11 |
| January 03, 2024 | 5.21 |
| January 02, 2024 | 4.80 |
| December 29, 2023 | 4.44 |
| December 28, 2023 | 4.68 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
2.50
Minimum
Mar 04 2024
120.12
Maximum
Jan 19 2021
39.23
Average
42.20
Median
Oct 03 2019
Total Return Level Benchmarks
| DBV Technologies SA | 0.6669 |
| Cellectis SA | 2.99 |
| Genfit SA | 3.66 |
| Innate Pharma SA | 2.545 |
| Inventiva SA | 3.30 |